Header Logo

Connection

JORGE E CORTES to Salicylates

Back to Details
This is a "connection" page, showing publications JORGE E CORTES has written about Salicylates.
JORGE E CORTES
Connection Strength
0.124
Salicylates
  1. Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies. Clin Lymphoma Myeloma Leuk. 2015 Jul; 15(7):433-438.e2.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.